PRIME MEDICINE INC (PRME) Stock Analyst Earnings Estimates
NASDAQ:PRME - Nasdaq - US74168J1016 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.983M | 6.769M 126.92% | 12.68M 87.32% | 30.538M 140.84% | -100.00% | 30.116M | 85.714M 184.61% | 293.85M 242.83% | 772.87M 163.02% | |||
| EBITDA YoY % growth | -114.32M -36.26% | -200.139M -75.07% | -196.339M 1.90% | -173.557M 11.60% | -141.48M 18.48% | -161.678M -14.28% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -116.54M -37.97% | -204.792M -75.73% | -202.467M 1.14% | -184.809M 8.72% | -159.87M 13.49% | -172.491M -7.89% | -188.964M -9.55% | -186.012M 1.56% | -136.252M 26.75% | 22.05M 116.18% | 372.34M 1,588.62% | |
| Operating Margin | N/A | N/A | -6,787.36% | -2,730.22% | -1,260.80% | -564.84% | N/A | -617.65% | -158.96% | 7.50% | 48.18% | |
| EPS YoY % growth | N/A | -2.18 26.93% | -1.65 24.31% | -1.32 19.87% | -1.03 21.93% | -0.95 7.89% | -0.86 9.09% | -0.81 6.40% | -0.69 14.28% | 0.28 140.44% | 1.90 578.18% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 19.38% | -0.30 31.66% | -0.25 17.94% | -0.30 26.22% |
| Revenue Q2Q % growth | 1.53M | 1.098M 425.36% | 4.697M 115.16% | -100.00% |
| EBITDA Q2Q % growth | -47.458M 10.15% | -41.847M 16.01% | -34.465M 9.53% | N/A |
| EBIT Q2Q % growth | -49.674M 10.77% | -43.399M 19.97% | -37.799M 14.52% | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.40 9.09% | -0.33 | -0.07 | -22.51% |
| Q4 2024 Q2Q % growth | -0.31 56.94% | -0.40 | 0.09 | 22.47% |
| Q3 2024 Q2Q % growth | -0.44 20.00% | -0.40 | -0.04 | -9.16% |
| Q2 2024 Q2Q % growth | -0.46 2.13% | -0.41 | -0.05 | -11.84% |
| Q1 2024 Q2Q % growth | -0.44 | -0.48 | 0.04 | 8.86% |
| Q4 2023 Q2Q % growth | -0.72 -28.57% | -0.52 | -0.20 | -38.48% |
| Q3 2023 Q2Q % growth | -0.55 | -0.47 | -0.08 | -17.22% |
| Q2 2023 Q2Q % growth | -0.47 | -0.43 | -0.04 | -8.85% |
| Q1 2023 Q2Q % growth | -0.44 | -0.42 | -0.02 | -4.20% |
| Q4 2022 Q2Q % growth | -0.56 | -0.67 | 0.11 | 15.86% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 1.454M 146.02% | 1.07M | 384K | 35.89% |
| Q4 2024 Q2Q % growth | 2.183M | 293.25K | 1.89M | 644.42% |
| Q3 2024 Q2Q % growth | 209K | 7.987M | -7.778M | -97.38% |
| Q2 2024 Q2Q % growth | 1.663M | -1.663M | -100.00% | |
| Q1 2024 Q2Q % growth | 591K | 165.75K | 425.25K | 256.56% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.55% | -11.71% | 0% | -6.36% |
| Revenue | 100% | 31.22% | 11.17% | 44.61% |